Pathway Capital Management’s Hinge Health HNGE Stock Holding History

Pathway Capital Management’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.73M	Buy	+79,492	New	+$6.97M	39.61%	2

Other funds holding HNGE

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Pathway Capital Management's HNGE Position: Q3 2026 in Review

Pathway Capital Management opened a new position in Hinge Health (HNGE) in Q3 2026: 79,492 shares worth $7.73M. The stake represents 39.61% of the portfolio and ranks #2 among its holdings.

130 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

Pathway Capital Management held 79,492 shares of Hinge Health worth $7.73M as of Q3 2026.
Hinge Health was a new Pathway Capital Management position in Q3 2026.
Hinge Health made up 39.61% of Pathway Capital Management's portfolio in Q3 2026, its #2 holding.
130 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Pathway Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.